Buprenorphine
- PMID: 24940223
- PMCID: PMC4051008
- DOI: 10.1107/S1600536814009672
Buprenorphine
Abstract
In the crystal structure of a semi-synthetic opioid drug buprenorphine, C29H41NO4 {systematic name: (2S)-2-[(5R,6R,7R,14S)-9α-cyclo-propyl-methyl-3-hy-droxy-6-meth-oxy-4,5-ep-oxy-6,14-ethano-morphinan-7-yl]-3,3-di-methyl-butan-2-ol}, the cyclo-propyl-methyl group is disordered over two sites with an occupancy factor of 0.611 (3) for the major component. One of the hy-droxy groups is involved in intra-molecular O-H⋯O hydrogen bond. The other hy-droxy group acts as a proton donor in an inter-molecular O-H⋯O inter-action that connects mol-ecules into a zigzag chain along the b axis.
Figures


References
-
- Allen, F. H., Johnson, O., Shields, G. P., Smith, B. R. & Towler, M. (2004). J. Appl. Cryst. 37, 335–338.
-
- Flippen-Anderson, J. L., George, C., Bertha, C. M. & Rice, K. C. (1994). Heterocycles, 39, 751–766.
-
- Hooft, R. W. W. (1998). COLLECT Nonius BV, Delft, The Netherlands.
-
- Huang, P., Kehner, G. B., Cowan, A. & Liu-Chen, L. Y. (2001). J. Pharmacol. Exp. Ther. 297, 688–695. - PubMed
-
- Kitajgorodskij, A. I. (1973). In Molecular Crystals and Molecules New York: Academic Press.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases